X0306
4
2018-07-02
0
0001419600
Flexion Therapeutics Inc
FLXN
0001598099
Bodick Neil
C/O FLEXION THERAPEUTICS, INC.
10 MALL ROAD, SUITE 301
BURLINGTON
MA
01803
0
1
0
0
Chief Scientific Officer
Common Stock
2018-07-02
4
S
0
33508
25.1042
D
78799
D
Common Stock
2018-07-03
4
S
0
16492
25.00
D
62307
D
Common Stock
1000
I
By spouse
Common Stock
388683
I
By Versant Development Fund III, LLC
Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted May 31, 2018.
The weighted average sale price for the transaction reported was $25.104229, and the range of prices were between $25 and $25.57. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The shares are held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.
/s/ Mark S. Levine, Attorney-in-Fact
2018-07-03